Geistlich Combi-Kit Collagen

Geistlich Combi-Kit Collagen contains Geistlich Bio-Oss® Collagen 100 mg and Geistlich Bio-Gide® 16 x 22 mm. Used together, the two combine optimal properties for ridge preservation and minor bone augmentation.

 

Leading clinicians rely on Geistlich Combi-Kit Collagen because:

  • Geistlich biomaterials are supported by scientific evidence and years of successful clinical experience.
  • Extraction socket management with the Geistlich Combi-Kit Collagen is a reliable option to preserve the ridge profile4-6.
  • GBR with Geistlich biomaterials provides long-term volume stability1 and space maintenance7.

Geistlich Combi-Kit Collagen is a convenient combination pack:

  • Geistlich Bio-Gide® 16 x 22 mm
  • Geistlich Bio-Oss® Collagen 100 mg

“Peri-implant defects can be treated successfully with the Geistlich Combi-Kit Collagen.”
Prof. Ronald E. Jung, Zurich, Switzerland

 

Geistlich Bio-Oss® Collagen is a natural bone substitute that maintains long-term volume1 and enhances new bone formation2. The Geistlich Bio-Oss® Collagen block is formable and easy to position into the defect site3.

Geistlich Bio-Gide® is a natural collagen membrane that promotes oral tissue healing in guided bone regeneration. The barrier properties of its bi-layer structure prevent premature ingrowth of soft tissue and support bone and soft-tissue regeneration.

 

References:

  1.  Mordenfeld A et al.,Clin. Oral Implant Res. 2010, Sep;21(9):961–70 (Clinical study).
  2.  Cardaropoli D et al., Int J Periodontics Restorative Dent. 2012 Aug;32(4):421–30 (Clinical study).
  3.  Trevisiol L et al., J Craniofac Surg. 2012 Sep;23(5):1343–8 (Clinical study).
  4.  Fickl S. et al., Journal of clinical periodontology 2008;35:356–363 (Preclinical study).
  5.  Ackermann KL, Int J Periodontics Restorative Dent. 2009 Oct;29(5):489-97 (Clinical study).
  6.  Perelman-Karmon M et al., Int J Periodontics Restorative Dent.2012 Aug;32(4):459–65 (Clinical study).
  7.  Jung RE et al., J Clin Periodontol. 2013 Jan;40(1):90–8 (Clinical study).

 

Verena Vermeulen
Senior Scientific Communication Manager